| Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Adolescent Smokers (NCT01148355) | National Institute on Drug Abuse (NIDA) | 2008-06-10 |
| Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients (NCT00780702) | National Institute on Drug Abuse (NIDA) | 2008-05-08 |
| Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence (NCT00687713) | National Institute on Drug Abuse (NIDA) | 2008-05-01 |
| Vigabatrin Ph 1 Cocaine Interaction Study (NCT00626834) | National Institute on Drug Abuse (NIDA) | 2008-02-01 |
| Effects of Smoking on Opioid Receptor Binding: A PET Study (NCT00618631) | National Institute on Drug Abuse (NIDA) | 2008-01-17 |
| Effects of Propranolol on Responses to Drug-Related Imagery Scripts (NCT00688805) | National Institute on Drug Abuse (NIDA) | 2007-12-12 |
| Psychology of Reward and Punishment: Functional and Molecular Brain Imaging and Monoaminergic Correlates (NCT00865332) | National Institute on Drug Abuse (NIDA) | 2007-12-12 |
| Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence (NCT00520286) | National Institute on Drug Abuse (NIDA) | 2007-12-01 |
| The Discriminative Effects of Tramadol in Humans (NCT00499746) | National Institute on Drug Abuse (NIDA) | 2007-11-01 |
| Preventing Substance Use and Risky Behavior Among Rural African American Youth (NCT00535704) | National Institute on Drug Abuse (NIDA) | 2007-11-01 |
| PET Imaging of Nicotinic Acetylcholine Receptors (NCT01046513) | National Institute on Drug Abuse (NIDA) | 2007-08-31 |
| Optimizing Toxicological Screening in Drug Endangered Children (NCT01037569) | National Institute on Drug Abuse (NIDA) | 2007-07-10 |
| Selegiline for Smoking Cessation - 1 (NCT00439413) | National Institute on Drug Abuse (NIDA) | 2007-06-01 |
| Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation (NCT01037608) | National Institute on Drug Abuse (NIDA) | 2007-05-08 |
| Ph1 Marinol Interaction Study - Part 1 - 1 (NCT00438139) | National Institute on Drug Abuse (NIDA) | 2007-03-01 |
| A Timeline Study of Alcohol Use and Its Relationship to Insomnia (NCT00580411) | National Institute on Drug Abuse (NIDA) | 2007-03-01 |
| The Neural Basis of Cue-Elicited Cigarette Craving and Its Control (NCT01048957) | National Institute on Drug Abuse (NIDA) | 2007-01-09 |
| Ph1 Marinol Interaction Study - Part 2 - 1 (NCT00490269) | National Institute on Drug Abuse (NIDA) | 2006-10-01 |
| Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia (NCT00218374) | National Institute on Drug Abuse (NIDA) | 2006-10-01 |
| Multi-Level HIV Prevention for Pregnant Drug Abusers (NCT01976702) | National Institute on Drug Abuse (NIDA) | 2006-10-01 |
| Evaluating Alternative Aftercare Models for Ex-offenders (NCT01586689) | National Institute on Drug Abuse (NIDA) | 2006-09-01 |
| The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215 (NCT01034800) | National Institute on Drug Abuse (NIDA) | 2006-09-01 |
| Screening Protocol for the Evaluation of Potential Research Subjects (NCT01036971) | National Institute on Drug Abuse (NIDA) | 2006-08-23 |
| Screening Protocol for the Evaluation of Research Participants (NCT01036217) | National Institute on Drug Abuse (NIDA) | 2006-05-17 |
| Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence (NCT01037075) | National Institute on Drug Abuse (NIDA) | 2006-05-14 |
| Rivastigmine For Methamphetamine Dependent Individuals (NCT00158210) | National Institute on Drug Abuse (NIDA) | 2006-05-01 |
| Efficacy of NicVAX in Smokers Who Want to Quit Smoking (NCT00318383) | National Institute on Drug Abuse (NIDA) | 2006-05-01 |
| Antagonist-Elicited Cannabis Withdrawal (NCT01041170) | National Institute on Drug Abuse (NIDA) | 2006-04-16 |
| Study of Smoking Abstinence (NCT01035632) | National Institute on Drug Abuse (NIDA) | 2006-04-07 |
| Topiramate for the Treatment of Methamphetamine Dependence - 1 (NCT00345371) | National Institute on Drug Abuse (NIDA) | 2006-04-01 |
| Effects of Nicotine on Elements of Attentions in Smokers and Nonsmokers (NCT01034020) | National Institute on Drug Abuse (NIDA) | 2006-02-14 |
| Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia (NCT01036568) | National Institute on Drug Abuse (NIDA) | 2006-02-14 |
| Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1 (NCT00519259) | National Institute on Drug Abuse (NIDA) | 2006-02-01 |
| Strategies to Help Adult ED Patients Quit Smoking (NCT00297466) | National Institute on Drug Abuse (NIDA) | 2006-01-01 |
| Emergency Department Initiated Tobacco Treatment (EDITT) (NCT00252902) | National Institute on Drug Abuse (NIDA) | 2005-12-01 |
| Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal Symptoms (NCT01603992) | National Institute on Drug Abuse (NIDA) | 2005-11-08 |
| Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients (NCT00295308) | National Institute on Drug Abuse (NIDA) | 2005-11-08 |
| Smoking and Alcohol Initiation (NCT00271843) | National Institute on Drug Abuse (NIDA) | 2005-10-01 |
| Effectiveness of Bupropion Combined With Behavioral Therapy for Treating Methamphetamine Dependence - 2 (NCT00135785) | National Institute on Drug Abuse (NIDA) | 2005-10-01 |
| Effect of Functional Genetic Polymorphisms on Brain Morphology and Function (NCT01035723) | National Institute on Drug Abuse (NIDA) | 2005-09-13 |
| Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2 (NCT00158145) | National Institute on Drug Abuse (NIDA) | 2005-09-01 |
| A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches (NCT00134927) | National Institute on Drug Abuse (NIDA) | 2005-09-01 |
| Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2 (NCT00158158) | National Institute on Drug Abuse (NIDA) | 2005-09-01 |
| Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1 (NCT00265265) | National Institute on Drug Abuse (NIDA) | 2005-08-01 |
| Impact of Smoking Cessation on Sleep - 5 (NCT00132821) | National Institute on Drug Abuse (NIDA) | 2005-08-01 |
| Effect of Clonidine on Responses to Imagery Scripts (NCT00318760) | National Institute on Drug Abuse (NIDA) | 2005-06-14 |
| Metabolic Effects of Cocaine (NCT00451230) | National Institute on Drug Abuse (NIDA) | 2005-06-01 |
| Smoking Treatment of Prisoners (NCT00110630) | National Institute on Drug Abuse (NIDA) | 2005-06-01 |
| Cognitive Task Development and Implementation for Functional MRI Studies (NCT01036685) | National Institute on Drug Abuse (NIDA) | 2005-05-22 |
| Drug Use Prevention Among Girls Through a Mother-Daughter Intervention (NCT00310258) | National Institute on Drug Abuse (NIDA) | 2005-04-01 |
| Effectiveness of Bupropion for Smokers Recovering From Alcohol Dependence (NCT00304707) | National Institute on Drug Abuse (NIDA) | 2005-04-01 |
| Addition of Naltrexone to Methadone Taper (NCT00135759) | National Institute on Drug Abuse (NIDA) | 2005-04-01 |
| Reward Processing in Cocaine Addiction (NCT01036074) | National Institute on Drug Abuse (NIDA) | 2005-03-17 |
| Dopamine Function and Reward Processing In Schizophrenia (NCT01035996) | National Institute on Drug Abuse (NIDA) | 2005-03-08 |
| Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1 (NCT00265278) | National Institute on Drug Abuse (NIDA) | 2005-03-01 |
| Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1 (NCT00218517) | National Institute on Drug Abuse (NIDA) | 2005-03-01 |
| Comparisons of Nicotine-free Cigarettes, Extra Low Nicotine Cigarettes vs. Medicinal Nicotine (NCT00777569) | National Institute on Drug Abuse (NIDA) | 2005-03-01 |
| Effectiveness of Bupropion in Treating Marijuana Dependent Individuals (NCT00142870) | National Institute on Drug Abuse (NIDA) | 2005-03-01 |
| fMRI Study of Nicotinic Effect on Neurophysiology of Schizophrenia (NCT01046526) | National Institute on Drug Abuse (NIDA) | 2005-02-08 |
| Tramadol to Reduce Opioid Withdrawal Symptoms (NCT00142896) | National Institute on Drug Abuse (NIDA) | 2005-02-01 |
| Step'n Out: A Multisite Trial of Collaborative Behavioral Management for Drug-Involved Parolees (NCT00302575) | National Institute on Drug Abuse (NIDA) | 2005-02-01 |
| Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking (NCT00248118) | National Institute on Drug Abuse (NIDA) | 2005-01-01 |
| Nicotine Lozenge to Reduce Smokeless Tobacco Use (NCT00218283) | National Institute on Drug Abuse (NIDA) | 2005-01-01 |
| Methylphenidate Studies for Drug Abuse Vulnerability Molecular Genentics (NCT00247689) | National Institute on Drug Abuse (NIDA) | 2004-12-22 |
| Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals (NCT00218049) | National Institute on Drug Abuse (NIDA) | 2004-12-01 |
| Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1 (NCT00129298) | National Institute on Drug Abuse (NIDA) | 2004-12-01 |
| Atomoxetine for the Treatment of Cannabis Dependence (NCT00167297) | National Institute on Drug Abuse (NIDA) | 2004-11-01 |
| Modafinil for the Treatment of Cocaine Dependence - 1 (NCT00100100) | National Institute on Drug Abuse (NIDA) | 2004-10-01 |
| To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1 (NCT00100074) | National Institute on Drug Abuse (NIDA) | 2004-09-01 |
| Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1 (NCT00094315) | National Institute on Drug Abuse (NIDA) | 2004-09-01 |
| Low-Cost Contingency Management for Hispanic Outpatients - 3 (NCT00249548) | National Institute on Drug Abuse (NIDA) | 2004-08-01 |
| Interactions Between Cocaine and Ethanol and Disulfiram - 1 (NCT00094289) | National Institute on Drug Abuse (NIDA) | 2004-08-01 |
| Integration of the Therapeutic Workplace in Drug Court (NCT00607360) | National Institute on Drug Abuse (NIDA) | 2004-08-01 |
| Effects of Fatty Acid Supplementation on Substance Dependent Individuals (NCT00312455) | National Institute on Drug Abuse (NIDA) | 2004-07-01 |
| Abuse Potential of Buprenorphine/Naloxone (NCT00149539) | National Institute on Drug Abuse (NIDA) | 2004-06-01 |
| Baclofen for the Treatment of Cocaine Dependence - 1 (NCT00082485) | National Institute on Drug Abuse (NIDA) | 2004-06-01 |
| Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1 (NCT00100113) | National Institute on Drug Abuse (NIDA) | 2004-06-01 |
| Assessment of Interactions Between Methamphetamine and Aripiprazole - 1 (NCT00089440) | National Institute on Drug Abuse (NIDA) | 2004-06-01 |
| Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids (NCT00218101) | National Institute on Drug Abuse (NIDA) | 2004-05-01 |
| Examining the Effectiveness of the Nicotine Patch in Male and Female Smokers - 2 (NCT00135746) | National Institute on Drug Abuse (NIDA) | 2004-05-01 |
| Effectiveness of Bupropion for Treating Nicotine Dependence in Young People (NCT00129272) | National Institute on Drug Abuse (NIDA) | 2004-05-01 |
| Implementing Tobacco Control in Dental Practice (NCT00297700) | National Institute on Drug Abuse (NIDA) | 2004-05-01 |
| A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder (NCT00593099) | National Institute on Drug Abuse (NIDA) | 2004-04-01 |
| GBR 12909 Study in Cocaine Experienced African American Volunteers - 1 (NCT00089687) | National Institute on Drug Abuse (NIDA) | 2004-04-01 |
| Neurobiology and Pharmacokinets of Acute MDMA Administration (NCT01148342) | National Institute on Drug Abuse (NIDA) | 2004-02-10 |
| Behavioral Smoking Cessation Treatment - 1 (NCT00110825) | National Institute on Drug Abuse (NIDA) | 2004-02-01 |
| Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management (NCT00292110) | National Institute on Drug Abuse (NIDA) | 2004-02-01 |
| Opioid Agonist and Antagonist Effects on Opioid Dependence (NCT00142727) | National Institute on Drug Abuse (NIDA) | 2004-01-01 |
| Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia (NCT00218231) | National Institute on Drug Abuse (NIDA) | 2004-01-01 |
| Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1 (NCT00218556) | National Institute on Drug Abuse (NIDA) | 2004-01-01 |
| A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1 (NCT00267657) | National Institute on Drug Abuse (NIDA) | 2004-01-01 |
| An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users (NCT00841477) | National Institute on Drug Abuse (NIDA) | 2004-01-01 |
| Contingency Management for Attendance - 2 (NCT00249639) | National Institute on Drug Abuse (NIDA) | 2004-01-01 |
| Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11 (NCT00015301) | National Institute on Drug Abuse (NIDA) | 2003-12-01 |
| Positive Choice: Prevention for Positive Health (NCT00447707) | National Institute on Drug Abuse (NIDA) | 2003-12-01 |
| Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging (NCT01036581) | National Institute on Drug Abuse (NIDA) | 2003-10-24 |
| Interaction Between Cocaine and Quetiapine - 1 (NCT00087750) | National Institute on Drug Abuse (NIDA) | 2003-10-01 |
| Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2 (NCT00135772) | National Institute on Drug Abuse (NIDA) | 2003-10-01 |
| A Transtheoretical Model Group Therapy for Cocaine (NCT00178776) | National Institute on Drug Abuse (NIDA) | 2003-10-01 |
| Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals (NCT00218309) | National Institute on Drug Abuse (NIDA) | 2003-09-01 |